LONDON--(BUSINESS WIRE)--Quantzig, a global data analytics and advisory firm, that delivers actionable analytics solutions to resolve complex business problems has announced the completion of its recent engagement during the course of which they helped a leading player in the precision medicine market to drive better outcomes using pharmacovigilance analytics.
The article also offers comprehensive insights on:
- The role of pharmacovigilance analytics in the precision medicine industry.
- How pharmacovigilance analytics solutions can accelerate drug discovery and development?
- The role of data mining in pharmacovigilance and its benefits.
Request a FREE proposal to gain comprehensive insights into our pharmacovigilance analytics solutions portfolio.
The precision medicine industry has experienced a watershed moment in drug discovery, as more and more pharma companies turn to big data and pharmacovigilance analytics to tackle challenges. The principle behind such ideas is driven by the uncertainties of relapses in drug discovery and the lack of adequate data management systems. However, with regulations continuing to emphasize patient safety, pharmacovigilance analytics will continue to play a pivotal role throughout the drug discovery & development phase. And those who lack the pharmacovigilance expertise and analytics tools, are poised to face challenges that can hinder drug discovery and development.
The growing complexities around drug discovery have made it crucial for precision medicine manufacturers to deploy a robust process to identify risks and extract product & indication-specific information. Speak to our analytics experts to get started!
The challenges faced by the client included:
- Inability to monitor and assess the benefit-risk profile of the medicinal products
- Lack of a robust strategy to drive improvements in drug discovery and drug development
Head to the success story to learn more about the challenges facing the precision medicine market: https://bit.ly/333XYoM
According to Quantzig’s advanced analytics experts, “Our pharmacovigilance solutions have empowered the broadest spectrum of pharmacovigilance, clinical, and other data management teams within the precision medicine market to easily access and analyze clinical data, identify trends, and opportunities with minimal support from IT teams.”
Collate, interpret, and analyze patient and drug safety data generated from disparate sources with personalized recommendations and guidance from our analytics experts. Book a FREE Demo now!
How Pharmacovigilance Analytics Helped the Precision Medicine Manufacturer
1: Reduced preparation time for drug safety reviews from days to hours
2: Identified and analyzed safety risks earlier in the drug development phase
3: Enhanced patient safety and accelerated drug development
The growing popularity of pharmacovigilance analytics within the precision medicine market can be attributed to its ability to enhance clinical data management by leveraging an improved drug development and safety monitoring process.
Quantzig’s advanced healthcare analytics solutions offer a unique way to work with pharmacovigilance data, find insights, and drive operational efficiency within the precision medicine market. Request a FREE brochure to gain comprehensive insights into our healthcare analytics portfolio.
[FREE Webinar Alert] - Join our analytics experts LIVE ( https://bit.ly/2TP9n7E ) as they share their thoughts on why businesses must factor in cannibalization while calculating marketing ROI.
Quantzig is a global analytics and advisory firm with offices in the US, UK, Canada, China, and India. For more than 15 years, we have assisted our clients across the globe with end-to-end data modeling capabilities to leverage analytics for prudent decision making. Today, our firm consists of 120+ clients, including 45 Fortune 500 companies. For more information on our engagement policies and pricing plans, visit: https://www.quantzig.com/request-for-proposal